IP Library Granted Patent US 10,533,994
Granted Patent B2
US 10,533,994 · App. 14/868,208 · Granted Jan 14, 2020

Systems and methods of sample processing and fluid control in a fluidic system

Inventors: Elizabeth A. Holmes (Palo Alto, CA); Shaunak Roy (Palo Alto, CA); Ian Gibbons (Palo Alto, CA); Shize Daniel Qi (Palo Alto, CA); Edmond Ku (Palo Alto, CA); Chris Todd (Palo Alto, CA); Melissa Takahashi (Palo Alto, CA); Bruce Johnson (Palo Alto, CA); Jeff Fenton (Palo Alto, CA); Keith Moravick (Palo Alto, CA); Uwe Springborn (Palo Alto, CA); Anthony Delacruz (Palo Alto, CA)
Assignee: Theranos IP Company, LLC
G01N33/5302A61B5/1411A61B5/1486A61B5/150022A61B5/15087A61B5/150213A61B5/150221A61B5/150229A61B5/150251A61B5/150274A61B5/150282A61B5/150412A61B5/150503A61B5/150755A61B5/150778A61B5/150786A61B5/150854A61B5/150862A61B5/150969A61B5/150984A61B5/412A61B5/685G01N33/536G01N33/573A61B5/157A61B5/15142G01N2333/46G01N2333/91188G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,533,994
App. No.
14/868,208
Granted
Jan 14, 2020
Kind
B2
Abstract

This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

Claims (36)

1. A system for detecting the presence or absence of an analyte in a bodily fluid sample obtained from a subject, comprising:

a cartridge, comprising:

a sample collection unit, comprising:

a sample collection well configured to receive a portion of the sample;

a metering channel in fluid communication with the sample collection well and configured such that the sample flows from the sample collection well into the metering channel; and

a metering element comprising a mechanically movable portion configured to be movable from an open position that permits fluid communication between the sample collection well and the metering channel to a closed position that does not provide fluid communication between the sample collection well, thereby isolating a specific volume of the sample in the metering channel;

a lysing assembly configured to lyse cells present in the sample; and

an assay assembly comprising a reaction site containing a reactant able to react with the analyte to yield a detectable signal indicative of the presence or absence of the analyte; and

a reader assembly comprising:

a detection assembly configured to detect the signal; and

a communication assembly configured to receive an assay protocol in response to receiving an identity of the cartridge from an external device, the external device being separate from the reader assembly, the communication assembly further configured to transmit the signal to the external device.

2. The system of claim 1 , wherein the metering element comprises a pin.

3. The system of claim 2 , wherein the pin is configured to be movable from an open position to a closed position, wherein the pin in the closed position blocks the metering channel.

4. The system of claim 2 , wherein the sample collection unit further comprises:

a dilution chamber in fluidic communication with the metering channel, wherein the dilution chamber is configured to store a diluent and comprises a port engaging pressure means transferring the diluent from the dilution chamber into the metering channel.

5. The system of claim 4 , wherein the sample collection unit further comprises a mixing chamber in fluidic communication with the metering channel, the mixing chamber being configured to mix the predetermined portion of the sample with the diluent to yield a diluted sample.

6. The system of claim 5 , wherein the sample collection unit further comprises a filter configured to filter the diluted sample before it is assayed.

7. The system of claim 1 , wherein the predetermined portion of the sample is less than about 50 μl.

8. The system of claim 1 , wherein the assay assembly is adapted to run an immunoassay.

9. The system of claim 8 , wherein the assay assembly comprises a reagent chamber in fluidic communication with the reaction site, wherein the reagent chamber is configured to store an assay reagent.

10. The system of claim 1 ,

wherein the reaction site of the assay assembly is in fluidic communication with the sample collection unit, the reaction site containing a reactant that reacts with the analyte to yield a signal indicative of the presence of the analyte; and the assay assembly further comprises:

a reagent chamber in fluidic communication with the reaction site, wherein the reagent chamber is configured to store an assay reagent;

a fluidic channel connecting the reagent chamber with the reaction site; and

an actuatable valve assembly configured to control the flow of reagent through the fluidic channel, wherein the valve assembly comprises a sealing element and actuator element, wherein

the channel comprises first and second locations,

wherein the sealing element positioned in the first location obstructs the flow of fluid through the channel and the sealing element positioned in the second location allows the flow of fluid through the channel, and

wherein the actuator element is adapted to move the sealing element from the first location to the second location.

11. The system of claim 10 , wherein the actuator element is adapted to be actuated by an actuator in a device in which the cartridge can be inserted.

12. The system of claim 11 , wherein the actuator element is adapted to be mechanically actuated by the actuator.

13. The system of claim 10 , wherein the second location has a larger cross section than the first location.

14. The system of claim 10 , wherein the actuator element comprises a sealing member such that when the actuator element moves the sealing element the sealing member forms a substantially air tight seal such that the fluid can only flow through the channel.

15. The system of claim 14 wherein the actuator element is substantially pin shaped and the sealing member is an O-ring adapted to be placed around the actuator element.

16. The fluidic device of claim 10 , wherein the assay assembly is adapted to run an immunoassay.

17. The system of claim 10 , wherein the sample of bodily fluid is less than 50 μl.

18. The system of claim 1 , wherein the assay protocol is transmitted wirelessly from the external device.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2023
From: LABRADOR DIAGNOSTICS LLC
To: GOLDEN DIAGNOSTICS TOP CORP.
Reel/Frame 064262/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2023
From: GOLDEN DIAGNOSTICS TOP CORP.
To: GOLDEN DIAGNOSTICS CORP.
Reel/Frame 064264/0393 →
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: HOLMES, ELIZABETH; ROY, SHAUNAK; GIBBONS, IAN; QI, SHIZE; KU, EDMOND; TODD, CHRIS; TAKAHASHI, MELISSA; JOHNSON, BRUCE; FENTON, JEFF; MORAVICK, KEITH; SPRINGBORN, UWE; DELACRUZ, ANTHONY
To: THERANOS, INC.
Reel/Frame 037364/0635 →
Continuity (9)
Continuation 14270618 · May 6, 2014
Continuation 11554509 · Oct 30, 2006
Continuation In Part 11388415 · Mar 24, 2006
Continuation In Part 11388823 · Mar 24, 2006
Continuation In Part 11388824 · Mar 24, 2006
Continuation In Part 11389409 · Mar 24, 2006
Continuation In Part 11389410 · Mar 24, 2006
Continuation In Part 11388723 · Mar 24, 2006
Related Publication 20160077086A1 · Mar 17, 2016
Cited By (2)
US 12,275,013 US 12,403,479